NO20012417L - Regulatoriske og utfoldende peptider av Ezrin - Google Patents

Regulatoriske og utfoldende peptider av Ezrin

Info

Publication number
NO20012417L
NO20012417L NO20012417A NO20012417A NO20012417L NO 20012417 L NO20012417 L NO 20012417L NO 20012417 A NO20012417 A NO 20012417A NO 20012417 A NO20012417 A NO 20012417A NO 20012417 L NO20012417 L NO 20012417L
Authority
NO
Norway
Prior art keywords
ezrin
regulatory
unfolding
peptides
unfolding peptides
Prior art date
Application number
NO20012417A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012417D0 (no
Inventor
Rupert Donald Holms
Original Assignee
Rupert Donald Holms
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rupert Donald Holms filed Critical Rupert Donald Holms
Publication of NO20012417D0 publication Critical patent/NO20012417D0/no
Publication of NO20012417L publication Critical patent/NO20012417L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20012417A 1999-09-17 2001-05-16 Regulatoriske og utfoldende peptider av Ezrin NO20012417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9921881A GB2354241A (en) 1999-09-17 1999-09-17 Regulatory/unfolding peptides of ezrin
PCT/GB2000/003566 WO2001025275A1 (en) 1999-09-17 2000-09-15 Regulatory/unfolding peptides of ezrin

Publications (2)

Publication Number Publication Date
NO20012417D0 NO20012417D0 (no) 2001-05-16
NO20012417L true NO20012417L (no) 2001-07-16

Family

ID=10861009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012417A NO20012417L (no) 1999-09-17 2001-05-16 Regulatoriske og utfoldende peptider av Ezrin

Country Status (23)

Country Link
US (1) US6849596B1 (da)
EP (2) EP1760090A1 (da)
JP (1) JP2003511389A (da)
KR (1) KR20010101017A (da)
CN (1) CN100387619C (da)
AT (1) ATE356144T1 (da)
AU (1) AU770208B2 (da)
BR (1) BR0007158A (da)
CA (1) CA2348780A1 (da)
CY (1) CY1106644T1 (da)
CZ (1) CZ20011689A3 (da)
DE (1) DE60033783T2 (da)
DK (1) DK1131348T3 (da)
ES (1) ES2283317T3 (da)
GB (1) GB2354241A (da)
HU (1) HUP0104254A3 (da)
NO (1) NO20012417L (da)
NZ (1) NZ511747A (da)
PL (1) PL348635A1 (da)
PT (1) PT1131348E (da)
RU (1) RU2215005C2 (da)
WO (1) WO2001025275A1 (da)
ZA (1) ZA200103938B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0301879D0 (en) * 2003-01-27 2003-02-26 Regent Res Llp HCV combination therapy
WO2007060440A2 (en) * 2005-11-23 2007-05-31 Regent Research L.L.P. The use of peptides in anti-ulcer therapy
CN100455665C (zh) * 2006-11-21 2009-01-28 汕头大学医学院 人食管癌细胞ezrin基因上游转录调控元件
WO2009103312A1 (en) * 2008-02-19 2009-08-27 Ludwig-Maximilians-Universität Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
RU2580629C1 (ru) * 2015-05-15 2016-04-10 Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ прогнозирования рецептивности эндометрия на основании оценки экспрессии и внутриклеточной локализации эзрина в эндометрии женщин с бесплодием и повторными неудачами программы эко
GB2546439B (en) 2015-06-01 2020-08-26 Nearmedic International Ltd Ezrin-derived peptides and pharmaceutical compositions thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290293A (en) * 1994-06-08 1995-12-20 Rupert Donald Holms Preparation which inhibits the autoimmune response in HIV, or SLE, patients
JP2000500322A (ja) * 1995-10-02 2000-01-18 アメリカ合衆国 初期癌検出への使用のための上皮タンパク質及びそのｄｎａ
US6399584B1 (en) * 1998-03-18 2002-06-04 Institute Curie Pharmaceutical composition containing ezrin mutated on tyrosine 353

Also Published As

Publication number Publication date
NZ511747A (en) 2004-03-26
GB9921881D0 (en) 1999-11-17
NO20012417D0 (no) 2001-05-16
WO2001025275A9 (en) 2002-07-25
PL348635A1 (en) 2002-06-03
EP1760090A1 (en) 2007-03-07
DE60033783D1 (de) 2007-04-19
CN1327450A (zh) 2001-12-19
DE60033783T2 (de) 2007-11-15
RU2215005C2 (ru) 2003-10-27
ATE356144T1 (de) 2007-03-15
AU7433300A (en) 2001-05-10
KR20010101017A (ko) 2001-11-14
AU770208B2 (en) 2004-02-19
ZA200103938B (en) 2002-05-15
CN100387619C (zh) 2008-05-14
ES2283317T3 (es) 2007-11-01
BR0007158A (pt) 2001-07-31
CA2348780A1 (en) 2001-04-12
EP1131348B1 (en) 2007-03-07
HUP0104254A2 (hu) 2002-04-29
GB2354241A (en) 2001-03-21
PT1131348E (pt) 2007-11-19
EP1131348A1 (en) 2001-09-12
WO2001025275A1 (en) 2001-04-12
CY1106644T1 (el) 2012-01-25
JP2003511389A (ja) 2003-03-25
HUP0104254A3 (en) 2002-05-28
DK1131348T3 (da) 2007-07-09
US6849596B1 (en) 2005-02-01
CZ20011689A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
FR12C0004I1 (da)
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE245417T1 (de) Pharmazeutische zubereitungen auf der basis von levodopa, carbidopa und entacapone
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
FI956078A0 (fi) Järjestelmä veren virusten inaktivoimiseksi
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
DK64592D0 (da) Peptider til terapeutisk behandling
ATE283278T1 (de) Peptid derivate
DE60029219D1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
SE9904377D0 (sv) Pharmaceutical combinations
ATE139531T1 (de) Arylsubstituierte rhodaninderivate
NO20041300L (no) Flavanolignanpreparater med okt loselighet
NO20012417L (no) Regulatoriske og utfoldende peptider av Ezrin
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
DE69330268D1 (de) Hämoregulierende peptide
EP0647138A4 (en) POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES.
FR2715304B1 (fr) Vaccin anti-allergique.
DE69726602D1 (en) Hepatitis b inhibitoren
EA200200927A1 (ru) Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
DE69739115D1 (de) Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung
NO996117D0 (no) Anordning for tilfoering av medikamenter samt behandling av virale og mikrobielle infeksjoner og taer ingssyndrom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application